RAPP Award Disclosure
Third Rock Ventures V, L.p. · SEC Form 4 · Filed Nov 3, 2026
Award
Calculated transaction value
$25M
Third Rock Ventures V, L.p. Director / Ten Percent Owner
RAPP
Rapport Therapeutics
RAPP
Transaction date
Oct 30, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 4 days later
RAPP daily price context
Close on/before transaction
$25.05
Oct 30, 2026
First close after public filing
$25.93
Nov 4, 2026
Return after filing · so far
-5.75%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,190,476 shares @ $21
- SEC ownership
- Indirect
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-445438
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$30M
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rapport Therapeutics, Inc. RAPP | Award | Oct 30, 2026 | $5M |
| Rapport Therapeutics, Inc. RAPP Current | Award | Oct 30, 2026 | $25M |